Pregnancy Registries for the MS Disease-Modifying Medications
The manufacturers of the FDA-approved disease-modifying medications establish pregnancy registries to monitor pregnancy outcomes in women who take one of these drugs within a week of becoming pregnant or while they are pregnant.